Abbott Medical Optics

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Abbott Medical Optics sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).

14 total trials none currently recruiting 13 completed top decile by trial count

Abbott Medical Optics: 14 sponsored US clinical trials, none currently recruiting.

Abbott Medical Optics sponsors 14 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 13 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataract, with 2 trials.

Top-decile sponsor footprint

Abbott Medical Optics ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 72/100

13 of 14 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

14 total, page 1 of 1

COMPLETED NA

Clinical Investigation of the Next-Generation Intraocular Lenses

NCT03372434
COMPLETED NA

Clinical Investigation of the Next-Generation Intraocular Lens

NCT03111550
COMPLETED NA

Post-Approval Study of the Tecnis® Toric IOL

NCT02566083
COMPLETED NA

Clinical Investigation of a New Intraocular Lens

NCT02203721
COMPLETED

Patient Perception of Visual Distortions

NCT02203747
COMPLETED

Patient Perception of Visual Quality and Function

NCT02146599
COMPLETED NA

Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refractive Errors

NCT01675479
COMPLETED Phase 1

Clinical Investigation of Expanded Designs of a Multifocal IOL

NCT01714635
COMPLETED NA

Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions

NCT01240122
COMPLETED NA

Clinical Evaluation of a New Viscoelastic for Cataract Surgery

NCT00972621
COMPLETED Phase 1

Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions

NCT01024855
COMPLETED Phase 3

Evaluation of an Investigational Multi-Purpose Solution (MPS)

NCT00961051
COMPLETED Phase 3

Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL)

NCT00747227
TERMINATED Phase 3

A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the Synchrony Dual Optic Intraocular Lens in Patients Undergoing Cataract Extraction

NCT00425464

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 3

Therapeutic Areas

Cataract 2
Hyperopia 1

How the Abbott Medical Optics archive is shaped

14 indexed studies, none listed as recruiting (0% open); 13 completed (93%).

Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).

Top condition: Cataract (2 trials), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Abbott Medical Optics: archived-pipeline peers nationwide

Peers matched on 14 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Abbott Medical Optics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share Abbott Medical Optics3-C Institute for Social DevelopmentAbbott RDx CardiometabolicAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAAerin Medical10xBio22nd Century Group23andMe3 Waves Wellness
Abbott Medical Optics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Abbott Medical Optics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 14 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Abbott Medical Optics page

14 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Optics or any single study.

  • None of Abbott Medical Optics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cataract is the condition Abbott Medical Optics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataract trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Abbott Medical Optics pipeline card: 14 registered trials from official public datasets.Report a data error.